DFAE Short Volume

Dimensional - Emerging Core Equity Market ETF (DFAE) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $9.15B, listed on AMEX, carrying a beta of 1.05 to the broader market. The fund is designed to purchase a broad and diverse group of readily marketable emerging markets securities that is composed of companies within the Emerging Markets Universe that meet the Advisor's investment criteria. public since 2020-12-03.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-06-01
Short Volume
383.1K
Total Volume
665.9K
Short %
57.54%
30-Day Avg Short %
58.04%

Showing 30 days of FINRA short volume data for Dimensional - Emerging Core Equity Market ETF.

Learn how short volume is reported and how to read the data →

Frequently asked DFAE short volume questions

What is the daily DFAE short volume?
As of Jun 1, 2026, Dimensional - Emerging Core Equity Market ETF (DFAE) short volume is 383.1K shares against 665.9K total reported volume, or 57.54% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is DFAE short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does DFAE short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.